Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.22%
SPX
+0.19%
IXIC
+0.31%
FTSE
-0.45%
N225
-1.05%
AXJO
+0.19%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
Health Care
abbv
Abbvie
NYSE: ABBV
-2.67 (-1.17%)
226.04
USD
At close at Dec 05, 21:33 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

publisher logo
Cashu

AbbVie’s Atogepant Shows Promise in Phase-3 Migraine Treatment Study Results

4 days ago
publisher logo
Cashu

AbbVie Launches Rinvoq for Ulcerative Colitis Treatment in Canada, Expanding Patient Options

7 days ago
publisher logo
Cashu

AbbVie Positioned for Growth Amid Surge in Healthcare Sector Investments and Innovations

9 days ago

Latest Abbvie News

prnewswire.com

AbbVie prsentiert auf dem 19. European Headache Congress Phase-3-Daten aus der ECLIPSE-Studie, die die berlegenheit von Atogepant (AQUIPTA) gegenber Placebo bei der Schmerzlinderung in der Akutbehandlung von Migrne belegen

Feature Image for interests on Clinical Trials & Medical Discoveries, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com
5 days ago
benzinga.com

AbbVie Scores Canadian Reimbursement Recommendations For Blockbuster Ulcerative Colitis Drug Skyrizi

Feature Image for interests on Biotech, Health Care, Healthcare, Large Cap from benzinga.com
9 days ago
benzinga.com

Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears

Feature Image for interests on ETF, Etfs, Health Care, Healthcare from benzinga.com
11 days ago
benzinga.com

How This 'Hidden Gold Mine' Has Beaten The Market For 30 Years

Feature Image for interests on Communication Services, Consumer Cyclical, Consumer Defensive, Consumer Discretionary from benzinga.com
13 days ago
benzinga.com

Unpacking the Latest Options Trading Trends in AbbVie

Feature Image for interests on Bzi-Uoa, ETF, Financial Services, Healthcare from benzinga.com
17 days ago
prnewswire.com

AbbVie Announces U.S. FDA Approval of EPKINLY (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma

Feature Image for interests on Fda Approval, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com
19 days ago
benzinga.com

A Look Into AbbVie Inc's Price Over Earnings

Feature Image for interests on Bzi-Pe, Healthcare, Intraday Update, Markets from benzinga.com
20 days ago
prnewswire.com

AbbVie Partners with Award-Winning Filmmaker on Film About the Dynamic and Resilient Lives of Those Living with Blood Cancer

Feature Image for interests on Energy, Entertainment, Film And Motion Picture, Health Care & Hospitals from prnewswire.com
23 days ago
benzinga.com

AbbVie Shares Rise To Intraday High After Key Trading Signal

Feature Image for interests on Contributors, Equities, Expert Ideas, Healthcare from benzinga.com
25 days ago
benzinga.com

What the Options Market Tells Us About AbbVie

about 1 month ago
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.